# Comparison Between Bupivacaine and Bupivacaine With Dexmedetomidine in Caudal Block for Post Operative Pain Control

> **NCT05919173** · PHASE4 · COMPLETED · sponsor: **Sindh Institute of Urology and Transplantation** · enrollment: 60 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Bupivacaine Hydrochloride 0.25% Injection Solution
- **DRUG:** Bupivacaine Hydrochloride 0.25% Injection plus Dexmedetomidine 1 microgram/kg body weight

## Key facts

- **NCT ID:** NCT05919173
- **Lead sponsor:** Sindh Institute of Urology and Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-10
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-11-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919173, "Comparison Between Bupivacaine and Bupivacaine With Dexmedetomidine in Caudal Block for Post Operative Pain Control". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05919173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*